Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Cumulative Catch-Up Adjustments Exact Science License Agreement, Cumulative Catch-Up Adjustments [Member] Exact Science License Agreement, Cumulative Catch-Up Adjustments Title of 12(b) Security Title of 12(b) Security Research and Development Services Exact Science License Agreement, Research and Development Services [Member] Exact Science License Agreement, Research and Development Services Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Document Fiscal Year Focus Document Fiscal Year Focus Performance obligation period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Adjustment to Compensation, Amount Adjustment to Compensation Amount Financial Instrument [Axis] Financial Instrument [Axis] Customer [Axis] Customer [Axis] Segment Reporting [Abstract] Segment Reporting [Abstract] Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Common stock, $0.0001 par value – 1,000,000,000 shares authorized; 110,870,300 and 67,944,192 shares issued and outstanding as of September 30, 2026, and December 31, 2025, respectively. Common Stock, Value, Issued 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Schedule of RSU Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Payments for taxes related to net settlement of equity awards Payment, Tax Withholding, Share-Based Payment Arrangement Accrued compensation and other related benefits Total accrued compensation and other related benefits Employee-related Liabilities, Current Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Increase in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Leases Lessee, Finance Leases [Text Block] Entity Ex Transition Period Entity Ex Transition Period Restatement Determination Date Restatement Determination Date Contract asset Contract with Customer, Asset, after Allowance for Credit Loss Total assets measured at fair value, Estimated Fair Value Cash Equivalents and Debt Securities Available-For-Sale, Excluding Accrued Interest, Current Cash Equivalents and Debt Securities Available-For-Sale, Current Perceptive Capital Solutions Corp. Perceptive Capital Solutions Corp. [Member] Perceptive Capital Solutions Corp. Cash equivalents, Amortized Cost Cash Equivalents, Amortized Cost Cash Equivalents, Amortized Cost Cash and cash equivalents and marketable securities Cash And Cash Equivalent And Debt Securities, Available-For-Sale, Excluding Accrued Interest, Current Cash And Cash Equivalent And Debt Securities, Available-For-Sale, Excluding Accrued Interest, Current Vesting of restricted stock units, net of shares withheld for taxes (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Number of securities called by warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Current income tax expense Current Income Tax Expense (Benefit) Conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Additions due to milestone achieved related to FDA approval Contract with Customer, Liability, Additions, Milestones Contract with Customer, Liability, Additions, Milestones Amendment Flag Amendment Flag Current liabilities: Liabilities, Current [Abstract] Accrued transaction costs Reverse Recapitalization, Accrued Transaction Costs Reverse Recapitalization, Accrued Transaction Costs Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Payments made on finance leases Finance leases Finance Lease, Principal Payments Short-term marketable securities, Gross Unrealized Loss Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Short-term marketable securities, Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss, Current Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization Material Right as Laboratory Tests Performed Material Right as Laboratory Tests Performed [Member] Material Right as Laboratory Tests Performed Total assets measured at fair value, Gross Unrealized Loss Cash Equivalents and Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax Cash Equivalents and Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax Leases [Abstract] Credit Spread Measurement Input, Credit Spread [Member] Issuance of common stock upon Business Combination to PCSC public shareholders and Sponsor, net of transaction costs Stock Issued During Period, Value, Acquisitions Related Party Transactions Related Party Transactions Disclosure [Text Block] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Research and Development Services Performed Research And Development Services Performed [Member] Research And Development Services Performed Reconciliation to amounts on the Condensed Consolidated Balance Sheets: Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation [Abstract] Entity Address, State or Province Entity Address, State or Province Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Long-term liabilities: Liabilities, Noncurrent [Abstract] Outstanding (in shares) Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Basic (in shares) Weighted-average shares of common stock outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Share-Based Payment Arrangement, Tranche One Share-Based Payment Arrangement, Tranche One [Member] Net accretion and amortization of investments in marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Exact Convertible Note Exact Convertible Note [Member] Exact Convertible Note Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current License and collaboration revenue License And Collaboration [Member] License And Collaboration 2030 Lessee, Operating Lease, Liability, to be Paid, Year Four Convertible note Convertible Debt, Noncurrent Customer relationships Customer Relationships [Member] Regulatory milestones Revenue, Remaining Performance Obligation, Regulatory Milestone Amount Revenue, Remaining Performance Obligation, Regulatory Milestone Amount Entity Address, City or Town Entity Address, City or Town Stock-based compensation Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Vested / released (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Class of Stock [Axis] Class of Stock [Axis] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Intangible assets, net Net Carrying Amount Intangible Asset, Finite-Lived, after Accumulated Amortization Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Level 2 Fair Value, Inputs, Level 2 [Member] Accumulated Amortization Intangible Asset, Finite-Lived, Accumulated Amortization Other income (expense), net: Nonoperating Income (Expense) [Abstract] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Payments of transaction costs related to the Business Combination Payments of Merger Related Costs, Financing Activities EarlyCDT Lung test plates EarlyCDT Lung Test Plates [Member] EarlyCDT Lung Test Plates Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] United States UNITED STATES RSUs released (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Recently Adopted Accounting Pronouncements and Recently Issued Accounting Standards Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Purchases of property and equipment in accounts payable and accrued expenses Capital Expenditures Incurred but Not yet Paid Deferred revenue Increase (Decrease) in Contract with Customer, Liability Loss from disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Use of Estimates Use of Estimates, Policy [Policy Text Block] Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Axis] Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Schedule of Accrued Compensation and Other Related Benefits Schedule of Accrued Liabilities [Table Text Block] Schedule of Liabilities Unobservable Input Reconciliation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Warrant exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Carrying value Long-Term Debt Schedule of Future Principal Contractual Obligations for Lease Commitments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Supplemental disclosures of noncash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Document Period End Date Document Period End Date Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net cash (used in) provided by investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Proceeds from related party transaction Proceeds from Related Party Transaction Proceeds from Related Party Transaction Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Aggregate principal amount Debt Instrument, Face Amount 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Beginning balance (in shares) Ending balance (in shares) Redeemable convertible preferred stock, outstanding (in shares) Temporary Equity, Shares Outstanding Operating costs and expenses: Costs and Expenses [Abstract] Security Exchange Name Security Exchange Name Stock converted, recapitalization (in shares) Stock Converted, Reverse Recapitalization Stock Converted, Reverse Recapitalization Net income (loss) – diluted Net Income (Loss) Attributable to Parent, Diluted Gross proceeds from Business Combination Proceeds From Reverse Recapitalization Transaction Proceeds From Reverse Recapitalization Transaction Weighted-average shares outstanding used in computing net income (loss) per share: Earnings Per Share, Basic, Other Disclosure [Abstract] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Reverse Recapitalization [Line Items] Reverse Recapitalization [Line Items] Reverse Recapitalization [Line Items] Finance leases Finance Lease, Weighted Average Remaining Lease Term Exercise of penny warrants (in shares) Stock Issued During Period, Shares, Penny Warrants Exercised Stock Issued During Period, Shares, Penny Warrants Exercised Total liabilities subject to fair value measurements on a recurring basis Liabilities, Fair Value Disclosure Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Convertible note remeasurement loss Change in fair value included in convertible note remeasurement loss Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Current portion of lease liabilities Less: Current portion of lease liabilities Operating Lease, Liability, Current Schedule of Property, Plant and Equipment, Net Property, Plant, and Equipment [Table Text Block] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Net Income (Loss) Per Share Attributable to Common Stockholders Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Net income (loss) per share: Earnings Per Share [Abstract] Earnings Per Share [Abstract] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Geographical [Domain] Geographical [Domain] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Unrecognized compensation cost, options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Company Selected Measure Name Company Selected Measure Name Purchases of marketable securities Payments to Acquire Debt Securities, Available-for-Sale Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Non-cash interest expense and amortization of debt issuance costs Amortization of Debt Issuance Costs and Discounts Related Party Transactions [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Residual Proceeds Roche License and Option Agreement, Residual Proceeds [Member] Roche License and Option Agreement, Residual Proceeds Individual: Individual [Axis] Warrants to purchase common stock Warrant [Member] Common stock, outstanding shares held by former Legacy Freenome equity holders (in shares) Common Stock, Shares, Outstanding, Legacy Common Stock, Shares, Outstanding, Legacy Diluted (in shares) Weighted-average shares of common stock outstanding - Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Noncash Consideration Roche License and Option Agreement, Noncash Consideration [Member] Roche License and Option Agreement, Noncash Consideration Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Shares issued upon redeemable conversion of convertible preferred stock (in shares) Temporary Equity, Shares Issued Upon Conversion Temporary Equity, Shares Issued Upon Conversion Commercial paper Commercial Paper [Member] U.S. treasury securities US Treasury Securities [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Issuance of common stock upon PIPE Financing, net of transaction costs (in shares) Issuance of common stock upon Business Combination and PIPE Financing, net of transaction costs (in shares) Stock Issued During Period, Shares, Reverse Recapitalization Stock Issued During Period, Shares, Reverse Recapitalization Less: Imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Accrued interest Accrued interest included in interest expense Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Accrued Interest Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Accrued Interest Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Laboratory machinery and equipment Laboratory Machinery and Equipment [Member] Laboratory Machinery and Equipment Other long-term assets Increase (Decrease) in Other Noncurrent Assets Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Roche Convertible Note Roche Convertible Note [Member] Roche Convertible Note Operating leases Operating Lease, Payments Award Timing Predetermined Award Timing Predetermined [Flag] Treasury Stock Treasury Stock, Common [Member] Weighted-average remaining lease term (in years): Weighted Average Remaining Lease Term [Abstract] Weighted Average Remaining Lease Term Available-for-sale securities Debt Securities, Available-for-Sale [Line Items] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Level 1 Fair Value, Inputs, Level 1 [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Customer One Customer One [Member] Customer One Total undiscounted lease payments Lessee, Operating Lease, Liability, to be Paid Area of lease Area of Real Estate Property Milestone Payment [Axis] Milestone Payment [Axis] Milestone Payment Other Noncancellable Unconditional Purchase Commitments Other Commitments [Table Text Block] Convertible note remeasurement loss Loss on fair-value remeasurement of convertible note Convertible Debt, Remeasurement Gain (Loss) Convertible Debt, Remeasurement Gain (Loss) Outstanding at beginning of period (in dollars per share) Outstanding at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value All Executive Categories All Executive Categories [Member] US Government Debt Securities US Government Debt Securities [Member] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Depreciation Depreciation Vesting [Domain] Vesting [Domain] Plan Name [Domain] Plan Name [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Number of RSUs Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Exercise price (in dollars per share) Outstanding at beginning of period (in dollars per share) Outstanding at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Operating lease right-of-use assets, net Operating Lease, Right-of-Use Asset Number of renewal options Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Material Right Roche License and Option Agreement, Material Right [Member] Roche License and Option Agreement, Material Right Renewal term Lessee, Operating Lease, Renewal Term Schedule of Basic and Diluted Net Income (Loss) per Share Attributable to Common Stockholders Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Segment and Geographic Information Segment Reporting [Text Block] Investments in Marketable Securities Investment in Debt and Equity Securities and Other Trading Assets [Text Block] Minimum Minimum [Member] Expiration Date Trading Arrangement Expiration Date Upfront Payments Exact Science License Agreement, Upfront Payments [Member] Exact Science License Agreement, Upfront Payments Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Schedule of Estimated Future Amortization Expense of Finite-Lived Intangible Assets Intangible Asset, Finite-Lived, Amortization Expense [Table Text Block] Income Statement Location [Axis] Location, Statement of Income, Balance [Axis] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Nonrelated Party Nonrelated Party [Member] Convertible note, at fair value Convertible Debt, Fair Value Disclosures Roche License and Option Agreement and Roche Promissory Note Agreement Roche License and Option Agreement and Roche Promissory Note Agreement [Member] Roche License and Option Agreement and Roche Promissory Note Agreement Vested stock options outstanding (in shares) Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Machinery and equipment Other Machinery and Equipment [Member] Percentage of ownership after transaction Sale of Stock, Percentage of Ownership after Transaction Common stock, authorized (in shares) Common Stock, Shares Authorized Fixed and Variable Consideration Roche License and Option Agreement, Fixed and Variable Consideration [Member] Roche License and Option Agreement, Fixed and Variable Consideration Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Remaining Weighted- Average Useful Life (in years) Intangible Asset, Finite-Lived, Useful Life Number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Option exercise fee payment period Collaborative Arrangement, Option Exercise Fee, Payment Period Collaborative Arrangement, Option Exercise Fee, Payment Period Exercise Price Award Exercise Price Vesting of restricted stock units, net of shares withheld for taxes Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Related Party Transaction [Axis] Related Party Transaction [Axis] Segment Reporting [Line Items] Segment Reporting [Line Items] Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount EarlyCDT Lung royalties EarlyCDT Lung Royalties [Member] EarlyCDT Lung Royalties Proceeds from maturities of marketable securities Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale Document Quarterly Report Document Quarterly Report EarlyCDT Lung test kits EarlyCDT Lung Test Kits [Member] EarlyCDT Lung Test Kits Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Temporary Equity [Line Items] Temporary Equity [Line Items] Effect of exchange rate changes on cash and cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Cash equivalents, Gross Unrealized Gain Cash Equivalents, Accumulated Gross Unrealized Gain, before Tax Cash Equivalents, Accumulated Gross Unrealized Gain, before Tax Debt Debt Disclosure [Text Block] Accrued interest Interest Payable Schedule of Investment in Marketable Securities Marketable Securities [Table Text Block] Unamortized discount and debt issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Service and other revenue Service And Other [Member] Service And Other Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Measurement Input Type [Domain] Measurement Input Type [Domain] Total operating costs and expenses Costs and Expenses Adoption Date Trading Arrangement Adoption Date Finance leases Finance Lease, Weighted Average Discount Rate, Percent Counterparty Name [Domain] Counterparty Name [Domain] Interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Sponsor Members Sponsor Members [Member] Sponsor Members Assets Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Total lease liabilities Operating Lease, Liability Insider Trading Policies and Procedures [Line Items] Finance lease obligation Finance Lease, Liability Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Deferred income tax expense Deferred Income Tax Expense (Benefit) Total assets measured at fair value, Gross Unrealized Gain Cash Equivalents and Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax Cash Equivalents and Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax Certain Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Thereafter Lessee, Operating Lease, Liability, to be Paid, After Year Four Lessee, Operating Lease, Liability, to be Paid, After Year Four Percentage of outstanding stock maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Commitment and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Recapitalization Reverse Recapitalization Disclosure [Text Block] Reverse Recapitalization Disclosure Number of operating segments Number of Operating Segments Outstanding potentially dilutive securities excluded from calculation of diluted net loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount RSUs Restricted stock units issued and outstanding Restricted Stock Units (RSUs) [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Central Index Key Entity Central Index Key Less: accumulated depreciation and amortization Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization All Adjustments to Compensation All Adjustments to Compensation [Member] Contract with Customer, Asset (Liability) [Roll Forward] Contract with Customer, Asset (Liability) [Roll Forward] Contract with Customer, Asset (Liability) Convertible Preferred Stock, Common Stock and Warrants Equity, Temporary Equity And Warrants Disclosure [Text Block] Equity, Temporary Equity And Warrants Disclosure Gross proceeds from private investment in public entity Proceeds from Issuance of Private Placement Equity [Abstract] Equity [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash used in operating activities Cash used in operations Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Income Statement [Abstract] Income Statement [Abstract] Stockholders’ Equity: Equity, Attributable to Parent [Abstract] Acquired developed technology Software, Purchased [Member] Document Transition Report Document Transition Report Ownership [Axis] Ownership [Axis] Accrued expenses and other current liabilities (includes $1,200 due to a related party as of September 30, 2026) Accrued expenses and other current liabilities Accrued and Other Liabilities, Current Accrued and Other Liabilities, Current Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Accrued other compensation related benefits Other Employee-related Liabilities, Current Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Schedule of Intangible Assets, Net Intangible Asset, Finite-Lived [Table Text Block] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] City Area Code City Area Code Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] All Individuals All Individuals [Member] Noncash lease expense Operating Lease, Right-of-Use Asset, Periodic Reduction Schedule of Segment Revenue by Geographic Location Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue [Table Text Block] Name Forgone Recovery, Individual Name Weighted average period for recognition of cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Previously Reported Previously Reported [Member] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted-Average Grant Date Fair Value Per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Long-term debt, measurement input Long-Term Debt, Measurement Input Statement Statement [Line Items] Total assets Assets Entity [Domain] Entity [Domain] Beginning balance Ending balance Contract with Customer, Asset (Liability) Contract with Customer, Asset (Liability) Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Total reserved shares for issuance of common stock (in shares) Common Stock, Capital Shares Reserved for Future Issuance Convertible Debt Convertible notes Convertible Debt [Member] Cash equivalents, Gross Unrealized Loss Cash Equivalents, Accumulated Gross Unrealized Loss, before Tax Cash Equivalents, Accumulated Gross Unrealized Loss, before Tax Interest expense Interest Expense, Nonoperating Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Offering expenses included in accounts payable Offering Expenses Incurred But Not Yet Paid Offering Expenses Incurred But Not Yet Paid Short-term marketable securities, Gross Unrealized Loss Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Reverse Recapitalization [Abstract] Reverse Recapitalization [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Proceeds from convertible note Proceeds from Convertible Debt Shares issued in PIPE financing (in shares) Stock Issued During Period, Shares, New Issues PEO PEO [Member] Additions related to development cost reimbursement received Contract with Customer, Liability, Additions, Reimbursements Contract with Customer, Liability, Additions, Reimbursements Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Roche Holdings Roche Holdings [Member] Roche Holdings Stock-based compensation expense Share-Based Payment Arrangement, Expense Other long-term liabilities (includes $1,140 due to a related party as of September 30, 2026) Other long-term liabilities Other Liabilities, Noncurrent Goodwill Goodwill Number of additional shares allowable under the plan (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Issuance of shares upon exercise of stock options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] SBX Evaluation Roche License and Option Agreement, SBX Evaluation [Member] Roche License and Option Agreement, SBX Evaluation Revenue recognized Contract with Customer, Liability, Revenue Recognized Number of performance obligations Revenue, Remaining Performance Obligation, Number Of Performance Obligations Revenue, Remaining Performance Obligation, Number Of Performance Obligations Accumulated Deficit Retained Earnings [Member] Lease liabilities, net of current portion Non-current lease liabilities Operating Lease, Liability, Noncurrent Money market funds Money Market Funds [Member] Revision of Prior Period [Domain] Revision of Prior Period [Domain] Forfeited or canceled (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Forfeited or canceled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Schedule of Fair Value Measurement Inputs Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Convertible note issuance costs Payments of Debt Issuance Costs Corporate bonds Corporate Debt Securities [Member] Diluted (in dollars per share) Net income (loss) per share attributable to common stockholders - diluted (in dollars per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Accrued compensation and other related benefits Increase (Decrease) in Employee Related Liabilities Amortization expense of finite-lived intangible assets Intangible Asset, Finite-Lived, Amortization Expense Interest expense on convertible debt Add: interest expense on convertible note Interest on Convertible Debt, Net of Tax Intangible Asset, Finite-Lived [Line Items] Intangible Asset, Finite-Lived [Line Items] Ownership [Domain] Ownership [Domain] Research and development Research and development Research and Development Expense Estimated Stock Price Measurement Input, Share Price [Member] Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Reimbursement for Development Costs Exact Science License Agreement, Reimbursement for Development Costs [Member] Exact Science License Agreement, Reimbursement for Development Costs Redeemable convertible preferred stock, par value (in dollars per share) Temporary Equity, Par or Stated Value Per Share Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Votes per share Common Stock, Voting Rights, Votes Per Share Common Stock, Voting Rights, Votes Per Share Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Property and equipment, net Total property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Collaboration Product Rating Collaboration Product Rating [Member] Collaboration Product Rating Total assets measured at fair value, Amortized Cost Cash Equivalents and Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss, Current Cash Equivalents and Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss, Current Financial Instruments [Domain] Financial Instruments [Domain] Intangible Asset, Finite-Lived, Class [Axis] Intangible Asset, Finite-Lived, Class [Axis] Conversion of redeemable convertible preferred stock into common stock in connection with reverse recapitalization Temporary Equity Converted Temporary Equity Converted Issuance of shares upon exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Revenue Revenue from Contract with Customer [Text Block] Coupon interest expense Coupon Interest Expense The amount of coupon interest expense. Forfeited or canceled (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Diagnostic and research services Diagnostic and Research Services [Member] Diagnostic and Research Services Construction in progress Construction in Progress [Member] Inventory Increase (Decrease) in Inventories Issuance of common stock upon Business Combination to PCSC public shareholders and Sponsor, net of transaction costs (in shares) Stock issued for acquisition (in shares) Stock Issued During Period, Shares, Acquisitions Shares upon conversion (in shares) Debt Conversion, Converted Instrument, Shares Issued Operating leases Operating Lease, Weighted Average Discount Rate, Percent Segment Reporting [Table] Segment Reporting [Table] Issuance of common stock upon conversion of convertible notes Stock Issued Related Party Transaction [Table] Related Party Transaction [Table] 2026 Equity Incentive Plan 2026 Equity Incentive Plan [Member] 2026 Equity Incentive Plan Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract] Schedule of Lease Costs and Supplemental Lease Information Lease, Cost [Table Text Block] Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Continuing Operation [Abstract] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Contract asset Contract with Customer, Liability, Additions, Contract Asset Contract with Customer, Liability, Additions, Contract Asset Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Income (loss) from operations Operating Income (Loss) Estimated incremental stock compensation cost Share-Based Payment Arrangement, Plan Modification, Estimated Incremental Cost Not Yet Incurred Share-Based Payment Arrangement, Plan Modification, Estimated Incremental Cost Not Yet Incurred Performance obligation amount Revenue, Remaining Performance Obligation, Amount Current Fiscal Year End Date Current Fiscal Year End Date 2026 (remainder of year) Other Commitment, to be Paid, Remainder of Fiscal Year Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Cash paid for amounts included in the measurement of lease liabilities: Cash Flow, Lessee [Abstract] Cash Flow, Lessee Related Party Transaction [Domain] Related Party Transaction [Domain] Issuance of common stock upon PIPE Financing, net of transaction costs Stock Issued During Period, Value, Reverse Recapitalization Stock Issued During Period, Value, Reverse Recapitalization Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Convertible Note Proceeds Exact Science License Agreement, Convertible Note Proceeds [Member] Exact Science License Agreement, Convertible Note Proceeds RA Capital RA Capital [Member] RA Capital Material Transfer Agreements Material Transfer Agreements [Member] Material Transfer Agreements Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Weighted-Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Recapitalization exchange ratio Recapitalization Exchange Ratio Recapitalization Exchange Ratio Common stock, issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Perceptive Advisors, LLC Perceptive Advisors, LLC [Member] Perceptive Advisors, LLC Satisfaction of Technology Transfers Satisfaction Of Technology Transfers [Member] Satisfaction Of Technology Transfers Incremental stock-based compensation expense Share-Based Payment Arrangement, Plan Modification, Incremental Cost Regulatory Approval of Collaboration Product Regulatory Approval Of Collaboration Product [Member] Regulatory Approval Of Collaboration Product Risk and Uncertainties Risk And Uncertainties, Policy [Policy Text Block] Risk And Uncertainties, Policy Revision of Prior Period, Adjustment Revision of Prior Period, Adjustment [Member] Equity Components [Axis] Equity Components [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Product and Service [Domain] Product and Service [Domain] Related Party Related Party [Member] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Entity Interactive Data Current Entity Interactive Data Current Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] 2026 Employee Stock Purchase Plan 2026 Employee Stock Purchase Plan [Member] 2026 Employee Stock Purchase Plan Entity Small Business Entity Small Business Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Termination Date Trading Arrangement Termination Date Shares withheld for tax withholding obligation (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Property, plant and equipment Property, Plant, and Equipment [Line Items] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Cash equivalents: Cash equivalents, Estimated Fair Value Cash Equivalents, Fair Value Disclosure Cash Equivalents, Fair Value Disclosure Other long-term assets Other Assets, Noncurrent Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract] Document Type Document Type Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Proceeds from PCSC trust account, net of redemptions Proceeds From Trust Account, Net of Redemptions Proceeds From Trust Account, Net of Redemptions Fair Value as of Grant Date Award Grant Date Fair Value Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Arrangement Duration Trading Arrangement Duration Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Deferred revenue, non-current, related party (includes $24,594 due to a related party as of September 30, 2026) Deferred revenue, non-current, related party Contract with Customer, Liability, Noncurrent Redeemable convertible preferred stock, authorized (in shares) Temporary Equity, Shares Authorized Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Commitments and contingencies (Note 13) Commitments and Contingencies Gross Carrying Amount Intangible Asset, Finite-Lived, before Accumulated Amortization Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Subtotal Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Proceeds from issuance of common stock upon Business Combination and PIPE Financing Net proceeds from Business Combination Reverse Recapitalization, Net Reverse Recapitalization, Net Finance lease amortization Finance Lease, Right-of-Use Asset, Amortization Revenue, Remaining Performance Obligation, Satisfaction Type [Axis] Revenue, Remaining Performance Obligation, Satisfaction Type [Axis] Revenue, Remaining Performance Obligation, Satisfaction Type Business Combination Business Combination [Policy Text Block] Counterparty Name [Axis] Counterparty Name [Axis] Furniture and fixtures Furniture and Fixtures [Member] Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Intangible Asset, Finite-Lived, Class [Domain] Intangible Asset, Finite-Lived, Class [Domain] Beginning balance Ending balance Carrying amount of redeemable convertible preferred stock Temporary Equity, Carrying Amount, Attributable to Parent Inventory Inventory, Net Award Type [Domain] Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Interest on finance lease liabilities Finance Lease, Interest Expense 2026 (remainder of year) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Warrants outstanding (in shares) Class of Warrant or Right, Outstanding Fair Value Measurements Fair Value Disclosures [Text Block] Milestone #1 Milestone Payment One [Member] Milestone Payment One Level 3 Fair Value, Inputs, Level 3 [Member] U.S. government agency bonds US Government Agencies Debt Securities [Member] Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] 2027 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year One Lease term Lessee, Operating Lease, Term of Contract Share price (in dollars per share) Share Price Ownership interest Subsidiary, Ownership Percentage, Noncontrolling Owner PEO Name PEO Name Geographical [Axis] Geographical [Axis] Redeemable convertible preferred stock, issued (in shares) Temporary Equity, Shares Issued Leasehold improvements Leasehold Improvements [Member] Restricted cash Restricted Cash Transaction price Contract with Customer, Liability Number of buildings related to lease Lessee, Operating Lease, Number Of Buildings Lessee, Operating Lease, Number Of Buildings Property, Plant and Equipment, Type [Axis] Long-Lived Asset, Class [Axis] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Legal Entity [Axis] Legal Entity [Axis] Total interest expense Interest Expense, Debt Regulatory Approval of Next-Generation Test Regulatory Approval Of Next-Generation Test [Member] Regulatory Approval Of Next-Generation Test Liability Class [Axis] Liability Class [Axis] Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Schedule of Finite-Lived Intangible Assets [Table] Intangible Asset, Finite-Lived [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Accounts payable Increase (Decrease) in Accounts Payable Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Variable consideration Revenue, Remaining Performance Obligation, Variable Consideration Amount Revenue, Remaining Performance Obligation, Variable Consideration Amount Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Exact Science License Agreement Exact Science License Agreement [Member] Exact Science License Agreement Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Milestone Payment [Domain] Milestone Payment [Domain] Milestone Payment [Domain] Debt Instrument [Axis] Debt Instrument [Axis] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense 2028 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Two Total lease cost Lease, Cost Purchase price of common stock, percent Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Issuance of common stock upon conversion of convertible notes (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Related party transaction amount Related Party Transaction, Amounts of Transaction Customer [Domain] Customer [Domain] Leases Lessee, Operating Leases [Text Block] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Basic (in dollars per share) Net income (loss) per share attributable to common stockholders - basic (in dollars per share) Earnings Per Share, Basic Measurement Input Type [Axis] Measurement Input Type [Axis] Deferred revenue, current Contract with Customer, Liability, Current Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Cost of services Cost of Revenue Award Type [Axis] Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts receivable (includes $8,000 accounts receivable from a related party as of September 30, 2026) Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Unrealized gain (loss) on available-for-sale securities Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Product and Service [Axis] Product and Service [Axis] Restricted cash Restricted Cash, Noncurrent Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Development payment satisfaction period Revenue, Remaining Performance Obligation, Development Payments, Satisfaction Period Revenue, Remaining Performance Obligation, Development Payments, Satisfaction Period Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common Stock Common Stock [Member] Operating lease cost Operating Lease, Cost Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Organization and Business Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Cover [Abstract] Cover [Abstract] Option exercise fee Collaborative Arrangement, Option Exercise Fee Collaborative Arrangement, Option Exercise Fee International Non-US [Member] Roche Convertible Debt Roche Convertible Debt [Member] Roche Convertible Debt Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Roche License and Option Agreement Roche License and Option Agreement [Member] Roche License and Option Agreement Revenue recognized Contract With Customer, Liability, Revenue Recognized Including Opening Balance Contract With Customer, Liability, Revenue Recognized Including Opening Balance Equity Awards Adjustments Equity Awards Adjustments [Member] Exclusive License and Option Agreement with Roche Collaborative Arrangement Disclosure [Text Block] Total liabilities and stockholders’ equity Liabilities and Equity Variable lease cost Variable Lease, Cost Accrued payroll and related expenses Accrued Salaries, Current Options Options to purchase common stock Employee Stock Option Share-Based Payment Arrangement, Option [Member] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Plan Name [Axis] Plan Name [Axis] Related and Nonrelated Parties [Domain] Related and Nonrelated Parties [Domain] PIPE Financing PIPE Financing [Member] PIPE Financing Milestone payments receivable Collaborative Arrangement, Milestone Payments Receivable Collaborative Arrangement, Milestone Payments Receivable Development payments Revenue, Remaining Performance Obligation, Development Payment Amount Revenue, Remaining Performance Obligation, Development Payment Amount Tabular List, Table Tabular List [Table Text Block] Vesting [Axis] Vesting [Axis] Additional paid-in capital Additional Paid in Capital Other long term liabilities Increase (Decrease) in Other Noncurrent Liabilities Other income (expense), net Other Nonoperating Income (Expense) 2029 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Three Dilutive effect of Roche convertible note (if-converted) (in shares) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 2026 (remainder of year) Intangible Asset, Finite-Lived, Estimated Amortization Expense, Remainder of Fiscal Year Name Awards Close in Time to MNPI Disclosures, Individual Name Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Forfeited or canceled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Series D Preferred Series D Preferred [Member] Series D Preferred General and administrative General and Administrative Expense Property, Plant and Equipment, Type [Domain] Long-Lived Asset, Class [Domain] Share purchase price (in dollars per share) Sale of Stock, Price Per Share Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Issuance of common stock upon conversion of convertible notes Stock Issued During Period, Value, Conversion of Convertible Securities 2016 Amended Plan 2016 Equity Incentive Plan [Member] 2016 Equity Incentive Plan Preferred stock, authorized (in shares) Preferred Stock, Shares Authorized Deferred offering costs related to reverse recapitalization Deferred Offering Costs, Reverse Recapitalization Deferred Offering Costs, Reverse Recapitalization Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Table] Preferred stock, $0.0001 par value – 10,000,000 shares authorized; no shares issued and outstanding as of September 30, 2026 and December 31, 2025 Preferred Stock, Value, Issued Accrued bonuses Accrued Bonuses, Current Adjustment to Compensation: Adjustment to Compensation [Axis] Milestone #2 Milestone Payment Two [Member] Milestone Payment Two Class of Stock [Domain] Class of Stock [Domain] Dilutive effect of stock options, warrants and RSUs (in shares) Incremental Common Shares Attributable to Dilutive Effect of Options, Warrants and Restricted Stock Units Incremental Common Shares Attributable to Dilutive Effect of Options, Warrants and Restricted Stock Units Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Transaction costs Payments of Reverse Recapitalization Transaction Costs Payments of Reverse Recapitalization Transaction Costs Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Marketable securities Short-term marketable securities: Short-term marketable securities, Estimated Fair Value Debt Securities, Available-for-Sale, Excluding Accrued Interest, Current Total Other Commitment Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Total assets subject to fair value measurements on a recurring basis Assets, Fair Value Disclosure Name Measure Name Revenue, Remaining Performance Obligation, Satisfaction Type [Domain] Revenue, Remaining Performance Obligation, Satisfaction Type [Domain] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Domain] Taxes Income Tax Disclosure [Text Block] Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Long-term debt Debt Instrument [Line Items] Conversion into common stock Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Conversions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Conversions Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Additional Paid-in Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Revision of Prior Period [Axis] Revision of Prior Period [Axis] Name Trading Arrangement, Individual Name Unrecognized compensation cost, excluding options Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Cash and cash equivalents Cash and Cash Equivalent Raw material inventory Inventory, Raw Materials, Net of Reserves Retirement of treasury stock Treasury Stock, Retired, Cost Method, Amount Company Selected Measure Amount Company Selected Measure Amount Investments, Debt and Equity Securities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization 2027 Other Commitment, to be Paid, Year One Entity Address, Address Line Two Entity Address, Address Line Two Current assets: Assets, Current [Abstract] Operating leases Operating Lease, Weighted Average Remaining Lease Term Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Lease liabilities arising from obtaining right-of-use assets Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Vested / released (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Temporary Equity, by Class of Stock [Table] Temporary Equity, by Class of Stock [Table] Purchase commitment Purchase Obligation Award Timing Method Award Timing Method [Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Net increase in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Common Shareholders Common Shareholders [Member] Common Shareholders Net income (loss) Net income (loss) Net loss Net income (loss) Net Income (Loss) Attributable to Parent Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Statement [Table] Statement [Table] Computer hardware and software Computer Hardware and Software [Member] Computer Hardware and Software Restatement Determination Date: Restatement Determination Date [Axis] Proceeds from issuance of common stock upon exercise of stock options Proceeds from Stock Options Exercised Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Series E Preferred Series E Preferred [Member] Series E Preferred Interest and investment income Investment Income, Interest Principal and accrued and unpaid interest automatically converted Debt Conversion, Converted Instrument, Amount Exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Evaluation period Collaborative Arrangement, Evaluation Period Collaborative Arrangement, Evaluation Period Total transaction costs Reverse Recapitalization, Accrued Transaction Costs and Payments of Transaction Costs Reverse Recapitalization, Accrued Transaction Costs and Payments of Transaction Costs Cash consideration Cash Acquired Through Reverse Recapitalization Cash Acquired Through Reverse Recapitalization Schedule of Changes in Deferred Revenue Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Weighted-average discount rate: Leases, Weighted Average Discount Rate [Abstract] Leases, Weighted Average Discount Rate Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Exclusive Commercialization License Exact Science License Agreement, Exclusive Commercialization License [Member] Exact Science License Agreement, Exclusive Commercialization License Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Accrued interest receivable Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Current Revenue: Revenues [Abstract] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Numerator: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]